title: Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007.
authors.affiliation: Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, California, USA. rauen@cc.ucsf.edu
authors.forename: Katherine A
authors.initials: KA
authors.lastname: Rauen
authors.forename: Erin
authors.initials: E
authors.lastname: Hefner
authors.forename: Kristin
authors.initials: K
authors.lastname: Carrillo
authors.forename: Jill
authors.initials: J
authors.lastname: Taylor
authors.forename: Laure
authors.initials: L
authors.lastname: Messier
authors.forename: Yoko
authors.initials: Y
authors.lastname: Aoki
authors.forename: Karen W
authors.initials: KW
authors.lastname: Gripp
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Matsubara
authors.forename: Virginia K
authors.initials: VK
authors.lastname: Proud
authors.forename: Peter
authors.initials: P
authors.lastname: Hammond
authors.forename: Judith E
authors.initials: JE
authors.lastname: Allanson
authors.forename: Marie-Ange
authors.initials: MA
authors.lastname: Delrue
authors.forename: Marni E
authors.initials: ME
authors.lastname: Axelrad
authors.forename: Angela E
authors.initials: AE
authors.lastname: Lin
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Doyle
authors.forename: Bronwyn
authors.initials: B
authors.lastname: Kerr
authors.forename: John C
authors.initials: JC
authors.lastname: Carey
authors.forename: Frank
authors.initials: F
authors.lastname: McCormick
authors.forename: Alcino J
authors.initials: AJ
authors.lastname: Silva
authors.forename: Mark W
authors.initials: MW
authors.lastname: Kieran
authors.forename: Aleksander
authors.initials: A
authors.lastname: Hinek
authors.forename: Tan T
authors.initials: TT
authors.lastname: Nguyen
authors.forename: Lisa
authors.initials: L
authors.lastname: Schoyer
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy*; D002809:Chondroitin Sulfates / Q000378:metabolism; D019465:Craniofacial Abnormalities / Q000235:genetics; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors; D011905:Genes, ras; D005838:Genotype; D018095:Germ-Line Mutation; D006330:Heart Defects, Congenital / Q000235:genetics; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000235:genetics; D010641:Phenotype; D013577:Syndrome
chemical_list: D004791:Enzyme Inhibitors; D019382:Human Growth Hormone; D002809:Chondroitin Sulfates; D051231:Farnesyltranstransferase